SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Ortin Laboratories gets nod to acquire 100% stake in Ortin Biotech

23 Jun 2011 Evaluate

Ortin Laboratories has received its board’s approval for the acquisition of 100% stake in Ortin Biotech. The company’s board gave its approval at the meeting held on June 18, 2011.

Further, the company is also in progress of merger of Vineet Laboratories with itself. Last year in July, Pharma major Ortin Laboratories’ board had decided to acquire Vineet Laboratories by way of merger / amalgamation.

Ortin Laboratories manufactures’ the complete range of Pharmaceutical Formulations of Tablets, Capsules, Syrups, Dry Powders & Ointments. Due to its concern for quality, the company stands as a leading and predominant pharmaceutical manufacturer of drugs and medicines of the country with turnover running in crores of rupees.

Ortin Global Share Price

14.47 0.00 (0.00%)
07-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1882.20
Dr. Reddys Lab 1290.00
Cipla 1341.45
Zydus Lifesciences 944.85
Lupin 2263.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×